The purpose of this observational study is to examine how slowing down blood flow to the legs- a practice called blood flow restriction (BFR)- during exercise by applying compression to the legs affects the way stem cells are released into the blood stream. This will be determined by drawing 6 cubic centimeters (ccs) of blood immediately post-exercise after the Delfi Personalized Tourniquet System (PTS) has been removed. 6 ccs of blood will also be taken prior to exercise and at the 20-, 40-, and 60-minute marks after exercise. The main question of this study is: • Will the levels of stem cells extracted before and after exercise be the same if blood flow is restricted during exercise? In this study, participants will undergo the following: * 6 ccs of blood extracted from the forearm prior to exercise to establish a baseline * 3 exercises- seated leg extension, semi-reclined leg press, and seated hamstring curl- consisting of 4 sets of 30-15-15-15 repetitions per exercise; resistance will be set to 30% of one-rep maximum (1-RM) * Additional 6 cc blood draws will be performed immediately post-exercise and after 20, 40, and 60 minutes have elapsed
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Concentration of Blood Lactate
Timeframe: 1 week after enrollment
Concentration of Blood Lactate
Timeframe: 2 weeks after enrollment
Concentration of Blood Lactate
Timeframe: 3 weeks after enrollment
Concentration of Blood Lactate
Timeframe: 4 weeks after enrollment
Concentration of Blood Lactate
Timeframe: 5 weeks after enrollment
Concentration of Blood Lactate
Timeframe: 6 weeks after enrollment
Prevalence of Hematopoietic Stem Cells
Timeframe: 1 week after enrollment
Prevalence of Hematopoietic Stem Cells
Timeframe: 2 weeks after enrollment
Prevalence of Hematopoietic Stem Cells
Timeframe: 3 weeks after enrollment
Prevalence of Hematopoietic Stem Cells
Timeframe: 4 weeks after enrollment
Prevalence of Hematopoietic Stem Cells
Timeframe: 5 weeks after enrollment
Prevalence of Hematopoietic Stem Cells
Timeframe: 6 weeks after enrollment